Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab : insights from the phase II PRIMMO trial
Bron
Gynecologic oncology - ISSN 0090-8258-191 (2024) p. 275-286
Long-term effects of the COVID-19 pandemic for patients with cancer
Bron
Quality of life research - ISSN 0962-9343-33:10 (2024) p. 2845-2853
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)
Bron
International journal of gynecological cancer - ISSN 1048-891X-34:8 (2024) p. 1217-1224
XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant
Bron
Translational oncology - ISSN 1936-5233-43 (2024) p. 1-13
Quality of surgery and treatment and its association with hospital volume : a population-based study in more than 5000 Belgian ovarian cancer patients
Bron
European journal of surgical oncology - ISSN 0748-7983-50:3 (2024) p. 1-8